Company · CIK 1671858

# ARS Pharmaceuticals, Inc.

| CIK | [1671858](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001671858) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | SPRY (Nasdaq) |
| First annual or quarterly report | 2021-03-29 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-284650 | Shelf Effective | 2025-01-31 | 2025-01-31 | 1 |
| 333-271359 | Shelf Effective | 2023-04-20 | 2023-05-03 | 2 |
| 333-261979 | Shelf Effective | 2022-01-03 | 2022-01-13 | 2 |
| 333-250009 | IPO Final prospectus | 2020-11-10 | 2020-12-04 | 5 |

## Filings

 11

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-01-31 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1671858/000119312525018480/0001193125-25-018480-index.htm) Shelf registered | 333-284650 | 0001193125-25-018480 |
| 2023-05-03 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1671858/999999999523001273/9999999995-23-001273-index.htm) Declared effective | 333-271359 | 9999999995-23-001273 |
| 2023-04-20 | [S-3](https://www.sec.gov/Archives/edgar/data/1671858/000119312523108478/0001193125-23-108478-index.htm) Shelf registered | 333-271359 | 0001193125-23-108478 |
| 2022-01-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1671858/999999999522000139/9999999995-22-000139-index.htm) Declared effective | 333-261979 | 9999999995-22-000139 |
| 2022-01-03 | [S-3](https://www.sec.gov/Archives/edgar/data/1671858/000119312522000630/0001193125-22-000630-index.htm) Shelf registered | 333-261979 | 0001193125-22-000630 |
| 2020-12-04 | [424B4](https://www.sec.gov/Archives/edgar/data/1671858/000119312520310601/0001193125-20-310601-index.htm) Final prospectus | 333-250009 | 0001193125-20-310601 |
| 2020-12-03 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1671858/999999999520003391/9999999995-20-003391-index.htm) Declared effective | 333-250009 | 9999999995-20-003391 |
| 2020-12-03 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1671858/000119312520308867/0001193125-20-308867-index.htm) Amendment | 333-250009 | 0001193125-20-308867 |
| 2020-11-30 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1671858/000119312520304858/0001193125-20-304858-index.htm) Amendment | 333-250009 | 0001193125-20-304858 |
| 2020-11-10 | [S-1](https://www.sec.gov/Archives/edgar/data/1671858/000119312520290236/0001193125-20-290236-index.htm) Registration filed | 333-250009 | 0001193125-20-290236 |
| 2020-10-02 | [DRS](https://www.sec.gov/Archives/edgar/data/1671858/000095012320010063/0000950123-20-010063-index.htm) Draft made public | 377-03623 | 0000950123-20-010063 |

[All filings of this company](https://equitycapital.markets/filings?cik=1671858) · [CSV](https://equitycapital.markets/filings.csv?cik=1671858)

---
Source page: https://equitycapital.markets/company/1671858 · Data: U.S. SEC EDGAR · CC BY 4.0